50 related articles for article (PubMed ID: 23121838)
1. Silymarin inhibits cell cycle progression and mTOR activity in activated human T cells: therapeutic implications for autoimmune diseases.
Gharagozloo M; Javid EN; Rezaei A; Mousavizadeh K
Basic Clin Pharmacol Toxicol; 2013 Apr; 112(4):251-6. PubMed ID: 23121838
[TBL] [Abstract][Full Text] [Related]
2. Azithromycin suppresses CD4(+) T-cell activation by direct modulation of mTOR activity.
Ratzinger F; Haslacher H; Poeppl W; Hoermann G; Kovarik JJ; Jutz S; Steinberger P; Burgmann H; Pickl WF; Schmetterer KG
Sci Rep; 2014 Dec; 4():7438. PubMed ID: 25500904
[TBL] [Abstract][Full Text] [Related]
3. Proteomics and Network Analyses Reveal Inhibition of Akt-mTOR Signaling in CD4
Karim AF; Sande OJ; Tomechko SE; Ding X; Li M; Maxwell S; Ewing RM; Harding CV; Rojas RE; Chance MR; Boom WH
Proteomics; 2017 Nov; 17(22):. PubMed ID: 28994205
[TBL] [Abstract][Full Text] [Related]
4. Silymarin inhibits dermal gelatinolytic activity and reduces cutaneous inflammation.
Mota J; Faria-Silva C; Resendes A; Santos MI; Carvalheiro MC; Lima A; Simões S
Nat Prod Res; 2024 Apr; ():1-12. PubMed ID: 38684022
[TBL] [Abstract][Full Text] [Related]
5. Immunosuppressive effect of silymarin on mitogen-activated protein kinase signalling pathway: the impact on T cell proliferation and cytokine production.
Gharagozloo M; Jafari S; Esmaeil N; Javid EN; Bagherpour B; Rezaei A
Basic Clin Pharmacol Toxicol; 2013 Sep; 113(3):209-14. PubMed ID: 23701595
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of mTOR signaling by quercetin in cancer treatment and prevention.
Bruning A
Anticancer Agents Med Chem; 2013 Sep; 13(7):1025-31. PubMed ID: 23272907
[TBL] [Abstract][Full Text] [Related]
7. Carnosine Inhibits the Proliferation of Human Gastric Carcinoma Cells by Retarding Akt/mTOR/p70S6K Signaling.
Zhang Z; Miao L; Wu X; Liu G; Peng Y; Xin X; Jiao B; Kong X
J Cancer; 2014; 5(5):382-9. PubMed ID: 24799956
[TBL] [Abstract][Full Text] [Related]
8. Silybin suppresses cell proliferation and induces apoptosis of multiple myeloma cells via the PI3K/Akt/mTOR signaling pathway.
Feng N; Luo J; Guo X
Mol Med Rep; 2016 Apr; 13(4):3243-8. PubMed ID: 26936429
[TBL] [Abstract][Full Text] [Related]
9. Silymarin impacts on immune system as an immunomodulator: One key for many locks.
Esmaeil N; Anaraki SB; Gharagozloo M; Moayedi B
Int Immunopharmacol; 2017 Sep; 50():194-201. PubMed ID: 28672215
[TBL] [Abstract][Full Text] [Related]
10. Pharmaceutical prospects of Silymarin for the treatment of neurological patients: an updated insight.
Ranjan S; Gautam A
Front Neurosci; 2023; 17():1159806. PubMed ID: 37274201
[TBL] [Abstract][Full Text] [Related]
11. Pleiotropic Biological Effects of Dietary Phenolic Compounds and their Metabolites on Energy Metabolism, Inflammation and Aging.
Villegas-Aguilar MDC; Fernández-Ochoa Á; Cádiz-Gurrea ML; Pimentel-Moral S; Lozano-Sánchez J; Arráez-Román D; Segura-Carretero A
Molecules; 2020 Jan; 25(3):. PubMed ID: 32013273
[TBL] [Abstract][Full Text] [Related]
12. EBV-LMP1 regulating AKT/mTOR signaling pathway and WWOX in nasopharyngeal carcinoma.
Qin L; Li X; Lin Z; Li H; Mo Y; Su F; Mo W; Yang Z
Int J Clin Exp Pathol; 2017; 10(8):8619-8625. PubMed ID: 31966718
[TBL] [Abstract][Full Text] [Related]
13. Silymarin Restores Regulatory T Cells (Tregs) Function in Multiple Sclerosis (MS) Patients In Vitro.
Shariati M; Shaygannejad V; Abbasirad F; Hosseininasab F; Kazemi M; Mirmosayyeb O; Esmaeil N
Inflammation; 2019 Aug; 42(4):1203-1214. PubMed ID: 30806958
[TBL] [Abstract][Full Text] [Related]
14. Differential regulation of CD4
Namdari H; Izad M; Rezaei F; Amirghofran Z
Daru; 2018 Dec; 26(2):215-227. PubMed ID: 30478656
[TBL] [Abstract][Full Text] [Related]
15. Immunoregulatory Effects of Silymarin on Proliferation and Activation of Th1 Cells Isolated from Newly Diagnosed and IFN-ß
Navabi F; Shaygannejad V; Abbasirad F; Vaez E; Hosseininasab F; Kazemi M; Mirmosayyeb O; Alsahebfosoul F; Esmaeil N
Inflammation; 2019 Feb; 42(1):54-63. PubMed ID: 30178232
[TBL] [Abstract][Full Text] [Related]
16. The Natural Agonist of Estrogen Receptor β Silibinin Plays an Immunosuppressive Role Representing a Potential Therapeutic Tool in Rheumatoid Arthritis.
Dupuis ML; Conti F; Maselli A; Pagano MT; Ruggieri A; Anticoli S; Fragale A; Gabriele L; Gagliardi MC; Sanchez M; Ceccarelli F; Alessandri C; Valesini G; Ortona E; Pierdominici M
Front Immunol; 2018; 9():1903. PubMed ID: 30174672
[TBL] [Abstract][Full Text] [Related]
17. Potential Role of Lipometabolism-Related MicroRNAs in Peripheral Blood Mononuclear Cells as Biomarkers for Coronary Artery Disease.
Dong J; Liang YZ; Zhang J; Wu LJ; Wang S; Hua Q; Yan YX
J Atheroscler Thromb; 2017 Apr; 24(4):430-441. PubMed ID: 27629254
[TBL] [Abstract][Full Text] [Related]
18. Natural Agents Used in Chemoprevention of Aerodigestive and GI Cancers.
Morris J; Fang Y; De Mukhopdhyay K; Wargovich MJ
Curr Pharmacol Rep; 2016 Feb; 2(1):11-20. PubMed ID: 27134816
[TBL] [Abstract][Full Text] [Related]
19. Potential Effects of Silymarin and Its Flavonolignan Components in Patients with β-Thalassemia Major: A Comprehensive Review in 2015.
Darvishi Khezri H; Salehifar E; Kosaryan M; Aliasgharian A; Jalali H; Hadian Amree A
Adv Pharmacol Sci; 2016; 2016():3046373. PubMed ID: 26997953
[TBL] [Abstract][Full Text] [Related]
20. Linking diet to acne metabolomics, inflammation, and comedogenesis: an update.
Melnik BC
Clin Cosmet Investig Dermatol; 2015; 8():371-88. PubMed ID: 26203267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
